Product Information

EFAVIRENZ 600 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $1.3491 per EA under NDC 31722050430. Its NADAC has been published 401 times since May 16, 2018.

FDA first approved this application on Apr 27, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EFAVIRENZ 600 MG TABLET

Efavirenz
$1.3491per EA

Strength

600 mg/1

NDC

31722050430

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

EFAVIRENZ

Approval Type

Generic (ANDA)

FDA Application

ANDA078886

FDA Approved

4/27/2018

TE Code

AB

On Market Since

4/27/2018

Pharmacological Classes

Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A Inducers
Cytochrome P450 3A4 Inhibitors
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors

Price Statistics

The NADAC for EFAVIRENZ 600 MG TABLET has been published 401 times since May 16, 2018, and over the history we have for it it has declined 95.1%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3491 per EA
All-time high$27.3463 (Aug 15, 2018)
All-time low$1.3206 (Feb 19, 2025)
52-week high$1.7446
52-week low$1.3491
Median price$5.4389
Average price$7.2870
Largest weekly change-43.3% (Mar 22, 2023)
Weeks tracked401
Tracking sinceMay 16, 2018

Price History

1W

-2.9%

1M

-2.9%

3M

-4.4%

6M

-1.8%

1Y

-21.4%

3Y

-56.2%

5Y

-75.2%

All

-95.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of EFAVIRENZ 600 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EFAVIRENZ 600 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $1.3491 per EA (NDC 31722050430), effective Aug 19, 2026.

How has the price of EFAVIRENZ 600 MG TABLET changed over time?

Over the history we have for it, the NADAC for EFAVIRENZ 600 MG TABLET has declined 95.1%. It has been tracked across 401 weekly CMS publications since May 16, 2018.

What are the highest and lowest recorded NADAC prices for EFAVIRENZ 600 MG TABLET?

Since May 16, 2018, the NADAC for EFAVIRENZ 600 MG TABLET has ranged from a low of $1.3206 (Feb 19, 2025) to a high of $27.3463 (Aug 15, 2018), with a median of $5.4389 per EA.

Are there cheaper alternatives to EFAVIRENZ 600 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as EFAVIRENZ 600 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures EFAVIRENZ 600 MG TABLET?

EFAVIRENZ 600 MG TABLET (NDC 31722050430) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.